Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GH Guardant Health Inc.

Trading 04-28 10:31:55 EDT

84.23

-4.27

-4.83%

High86.60	Low83.27	Vol480.05K
Open86.04	D1 Closing88.50	Amplitude3.76%
Mkt Cap11.05B	Tradable Cap10.61B	Total Shares131.17M
T/O40.79M	T/O Rate0.38%	Tradable Shares126.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":84.225,"timestamp":1777386711833,"preClose":88.5,"halted":0,"volume":480054,"delay":0,"changeRate":-0.048305084745762776,"floatShares":126000000,"shares":131170441,"eps":-3.320281,"marketStatus":"Trading","change":-4.275,"latestTime":"04-28 10:31:55 EDT","open":86.04,"high":86.6,"low":83.27,"amount":40791302.10528,"amplitude":0.037627,"askPrice":84.44,"askSize":20,"bidPrice":83.99,"bidSize":201,"shortable":3,"etf":0,"ttmEps":-3.320281,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1777406400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":88.5,"preHourTrading":{"tag":"盘前","latestPrice":88.5,"preClose":88.5,"latestTime":"09:05 EDT","volume":10559,"amount":934442.35716,"timestamp":1777381513456,"change":0,"changeRate":0,"amplitude":0.115977},"postHourTrading":{"tag":"盘后","latestPrice":89,"preClose":88.5,"latestTime":"19:37 EDT","volume":25562,"amount":2262059.64,"timestamp":1777333053049,"change":0.5,"changeRate":0.00565,"amplitude":0.011299},"volumeRatio":1.723105,"impliedVol":0.8271,"impliedVolPercentile":0.992},"requestUrl":"/m/hq/s/GH/wiki","defaultTab":"wiki","newsList":[{"id":"2630134338","title":"Guardant Health Says Chief Medical Officer to Resign","url":"https://stock-news.laohu8.com/highlight/detail?id=2630134338","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630134338?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:40","pubTimestamp":1777326012,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) said late Monday in a regulatory filing its chief medical officer, Craig Eagle, will resign, effective May 8.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4196","GH","BK4535","BK4551","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630034862","title":"Guardant Health Chief Medical Officer Craig Eagle resigns, effective May 8","url":"https://stock-news.laohu8.com/highlight/detail?id=2630034862","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630034862?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:12","pubTimestamp":1777324346,"startTime":"0","endTime":"0","summary":"Guardant Health disclosed resignation of Chief Medical Officer Craig Eagle, M.D., effective May 8, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL46DHyF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4551","GH","BK4196","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629720276","title":"H.C. Wainwright Keeps Their Buy Rating on GH Research (GHRS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629720276","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629720276?lang=en_us&edition=fundamental","pubTime":"2026-04-21 01:36","pubTimestamp":1776706578,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on GH Research, with a price target of $70.00. According ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-gh-research-ghrs-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-gh-research-ghrs-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GHRS","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628072432","title":"GH Research Up Nearly 22%, on Track for Highest Close Since January 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2628072432","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628072432?lang=en_us&edition=fundamental","pubTime":"2026-04-20 23:05","pubTimestamp":1776697500,"startTime":"0","endTime":"0","summary":"GH Research Plc  is currently at $22.32, up $3.98 or 21.67%. --Would be highest close since Jan. 3, 2022, when it closed at $23.98. --On pace for largest percent increase since Jan. 7, 2026, when it rose 27.12%. --Currently up nine consecutive days; up 52.01% over this period. --Down 20.02% from its all-time closing high of $27.90 on Nov. 9, 2021. --Up 143.35% from 52 weeks ago , when it closed at $9.17. --Traded as high as $24.66; highest intraday level since Dec. 28, 2021, when it hit $25.10. --Up 34.46% at today's intraday high; largest intraday percent increase since Jan. 5, 2026, when it rose as much as 43.5%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GH","GHRS","BK4007","BK4196","BK4535","BK4551","BK4588","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628072560","title":"GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness","url":"https://stock-news.laohu8.com/highlight/detail?id=2628072560","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628072560?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:00","pubTimestamp":1776690000,"startTime":"0","endTime":"0","summary":"DUBLIN, April  20, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3277100/0/en/GH-Research-Welcomes-White-House-Executive-Order-to-Accelerate-Medical-Treatments-for-Serious-Mental-Illness.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4585","BK4588","BK4551","BK4535","AAQC","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628240546","title":"Guardant Health director Tariq Musa sells 116 shares worth $9,840.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2628240546","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628240546?lang=en_us&edition=fundamental","pubTime":"2026-04-17 07:59","pubTimestamp":1776383976,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa reported sale of 116 common shares on April 16 at USD 84.83.Filing shows Musa held 8,528 common shares following transaction.He also reported vesting of 250 restricted stock units into common stock on April 15 at USD 0.Derivative holdings included 2,749 restricted stock units after vesting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL4RHGfW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health director Tariq Musa sells 116 shares worth $9,840.28","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","GH","BK4551","BK4535","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628246271","title":"Guardant Health to report first-quarter results after market close, host conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2628246271","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628246271?lang=en_us&edition=fundamental","pubTime":"2026-04-17 04:05","pubTimestamp":1776369954,"startTime":"0","endTime":"0","summary":"Guardant Health schedules first-quarter 2026 financial results release for May 7, 2026.Management webcast conference call set for May 7 at 1:30 p.m. PT.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via Business Wire  on April 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL1Nm81M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4588","BK4196","BK4585","GH","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627422877","title":"Guardant Health Is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2627422877","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627422877?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:03","pubTimestamp":1776200580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2026 17:03 ET (21:03 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4551","GH","BK4196","BK4535","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627413278","title":"U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2627413278","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627413278?lang=en_us&edition=fundamental","pubTime":"2026-04-14 15:45","pubTimestamp":1776152709,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution MedicinesApril 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biog","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL4N40X0LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BE","ADPT","MAA","ADGM","CBRE","BL","MRNY","NSA","GIS","SJM","MSFL","MRNA","CAI","GH","ASAN","CUBE","HSY","MSFO","CPB","LNG","MSFD","IDYA","MSFX","TREE","PODD","EXR","HUBS","EQIX","MSFT","BRBR","AVB","CPT","BEG","DLR","BDX","MRNX","FLS","NEO","BIIB","BEX","MSFU","CAG","NTRA","WGS","MSFY","JAN","INSP","BSX","KHC","MKC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626108663","title":"Cloudflare, ServiceNow, And Guardant Health Are Among Top 10 Large-Cap Losers Last Week (April 6-April 10): Are the Others in Your Portfolio?","url":"https://stock-news.laohu8.com/highlight/detail?id=2626108663","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626108663?lang=en_us&edition=fundamental","pubTime":"2026-04-12 22:33","pubTimestamp":1776004380,"startTime":"0","endTime":"0","summary":"Macro concerns, AI competition, and analyst downgrades drove broad weekly losses across software and cloud stocks, led by Akamai, Okta, and Cloudflare.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/12/Servicenow-Office-Building-At-Their-Head.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/12/Servicenow-Office-Building-At-Their-Head.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/04/51770668/cloudflare-servicenow-and-guardant-health-are-among-top-10-large-cap-losers-last-week-april-6-april-10-are-the-others-in-your-portfolio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/04/51770668/cloudflare-servicenow-and-guardant-health-are-among-top-10-large-cap-losers-last-week-april-6-april-10-are-the-others-in-your-portfolio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["HUBS","XDAT","ONEQ","QDTE","QID","IE00BZ9MQY76.HKD","INTU","SNOY","AKAM","NET","NETX","NVIW.SI","SNOW","BK4023","TEAM","LU0124676726.USD","OKTA","OKTG","SNOU","GH","IYW",".IXIC","QYLG","SQQQ","QQQE","LU2125909593.SGD","QQQJ","QQQY","IOT","FTEC","PSQ","LU1551013342.USD","LU2063271972.USD","NOWL","OKTX","NOW","QQQ","MNQmain","TQQY","QQQM","NETG","BK4560","JEPQ","NQmain","TQQQ","QLD","LU1934455863.HKD","QQQA","GPIQ","NDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626126064","title":"Oscar, Guardant, Redwire, Gap, AFLAC: Insider Moves Shock Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2626126064","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626126064?lang=en_us&edition=fundamental","pubTime":"2026-04-11 21:01","pubTimestamp":1775912460,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($OSCR)), (($GH)), (($RDW)), (($GAP)) and (($AFL)). Here is a breakdown of their recent trades and thei...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/oscar-guardant-redwire-gap-aflac-insider-moves-shock-wall-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/oscar-guardant-redwire-gap-aflac-insider-moves-shock-wall-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4162","OSCG","GH","BK4551","GAP","RDW","OSCR","AFL","OSCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625287579","title":"OS Therapies appoints Guardant Health CMO Craig Eagle to strategic advisory board","url":"https://stock-news.laohu8.com/highlight/detail?id=2625287579","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625287579?lang=en_us&edition=fundamental","pubTime":"2026-04-08 23:39","pubTimestamp":1775662754,"startTime":"0","endTime":"0","summary":"OS Therapies appointed Craig Eagle, MD to newly formed strategic advisory board on April 8, 2026.Mandate includes pipeline prioritization beyond osteosarcoma as company advances clinical-stage oncology programs.Eagle is Chief Medical Officer at Guardant Health.Career background includes senior oncology leadership roles at Genentech, Pfizer.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL9HT053:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002224.SGD","LU0122379950.USD","IE000M9KFDE8.USD","SG9999013999.USD","BK4535","BK4592","BK4588","BK4007","LU0306806265.USD","GH","LU0058720904.USD","LU1894683264.USD","LU0234572021.USD","OSTX","BK4196","BK4568","LU0289739699.SGD","BK4585","LU1066053197.SGD","SG9999001176.USD","LU1023059063.AUD","SG9999001176.SGD","SG9999003800.SGD","BK4534","IE00BLSP4452.SGD","BK4139","LU0306807586.USD","SG9999002232.USD","IE00BBT3K403.USD","LU0321505868.SGD","LU0985481810.HKD","LU1894683348.USD","LU0170899867.USD","IE00B19Z3581.USD","LU1883839398.USD","BK4599","LU0321505439.SGD","LU0225771236.USD","IE00BLSP4239.USD","BK4581","LU0456855351.SGD","LU1057294990.SGD","SGXZ57979304.SGD","LU0868494617.USD","LU0225284248.USD","BK4533","BK4550","SG9999011175.SGD","BK4551","IE00B19Z3B42.SGD","LU1066051498.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625618299","title":"Guardant Health Chief People Officer Terilyn Monroe disposes 3,832 shares for $355,550.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2625618299","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625618299?lang=en_us&edition=fundamental","pubTime":"2026-04-08 05:40","pubTimestamp":1775598042,"startTime":"0","endTime":"0","summary":"Guardant Health Chief People Officer Terilyn J. Monroe sold 3,832 shares on April 6 at USD 92.68.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL3TBPGZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief People Officer Terilyn Monroe disposes 3,832 shares for $355,550.56","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4588","BK4196","GH","BK4585","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625931779","title":"Citi adds ‘upside 90-day catalyst watch’ on Guardant Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2625931779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625931779?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:10","pubTimestamp":1775556633,"startTime":"0","endTime":"0","summary":"Citi added an “upside 90-day catalyst watch” on shares of Guardant Health (GH) while keeping a Buy rating on the name with a $150 price target Citi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-adds-upside-90-day-catalyst-watch-on-guardant-health-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-adds-upside-90-day-catalyst-watch-on-guardant-health-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","GH","BK4585","BK4588","BK4551","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625603525","title":"Guardant Health Is Maintained at In-Line by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2625603525","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625603525?lang=en_us&edition=fundamental","pubTime":"2026-04-07 01:37","pubTimestamp":1775497020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 06, 2026 13:37 ET (17:37 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4585","BK4588","BK4551","BK4535","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625679769","title":"Guardant Health price target lowered to $90 from $110 at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2625679769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625679769?lang=en_us&edition=fundamental","pubTime":"2026-04-06 20:18","pubTimestamp":1775477933,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Guardant Health (GH) to $90 from $110 and keeps an In Line rating on the shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-lowered-to-90-from-110-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-lowered-to-90-from-110-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4551","GH","BK4196","BK4535","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623310287","title":"Guardant Health announces evidence generated from InfinityAI","url":"https://stock-news.laohu8.com/highlight/detail?id=2623310287","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623310287?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:37","pubTimestamp":1774874230,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that real-world evidence generated from Guardant’s InfinityAI contributed to the recent approval of ENHERTU, develop...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-announces-evidence-generated-from-infinityai-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-announces-evidence-generated-from-infinityai-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4551","GH","BK4588","BK4196","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623731762","title":"Guardant InfinityAI real-world evidence supports Japan approval of ENHERTU for HER2+ tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2623731762","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623731762?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:10","pubTimestamp":1774872612,"startTime":"0","endTime":"0","summary":"Guardant Health reported real-world evidence generated by its InfinityAI platform supported Japan MHLW clearance for ENHERTU in previously treated patients with HER2-positive advanced or recurrent solid tumors.Evidence was used as supplemental data alongside results from HERALD, DESTINY-PanTumor02, DESTINY-CRC02, DESTINY-Lung01 clinical studies.Analysis drew on outcomes from a large cohort with HER2 amplifications detected via Guardant360, highlighting unmet need across multiple tumor types.Guardant positioned InfinityAI as a pathway to expand regulatory submissions in low-prevalence, biomarker-defined populations where trial enrollment is limited.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the origin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL4wbwH7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4196","BK4535","BK4551","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623317344","title":"Guardant Health’s Infinityai Real-World Evidence Supports Approval of Enhertu® for Previously Treated Patients With Her2-Positive Metastatic Solid Tumors in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2623317344","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623317344?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:05","pubTimestamp":1774872306,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nFWN40I0NH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BK4535","BK4588","BK4551","BK4585","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622689008","title":"GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2622689008","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622689008?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:49","pubTimestamp":1774453776,"startTime":"0","endTime":"0","summary":"An announcement from GH Research ( ($GHRS) ) is now available. On March 25, 2026, GH Research PLC reported that full results from its randomized, d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gh-research-publishes-phase-2b-gh001-trd-data-and-highlights-severity-independent-efficacy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gh-research-publishes-phase-2b-gh001-trd-data-and-highlights-severity-independent-efficacy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","GH","BK4551","BK4535","BK4196"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":-0.0282},{"period":"1month","weight":0.046},{"period":"3month","weight":-0.2277},{"period":"6month","weight":0.2246},{"period":"1year","weight":0.8323},{"period":"ytd","weight":-0.1335}],"compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.1279},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.0404},{"period":"1year","weight":0.2988},{"period":"ytd","weight":0.0488}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.071093},{"month":2,"riseRate":0.25,"avgChangeRate":0.034152},{"month":3,"riseRate":0.5,"avgChangeRate":-0.022808},{"month":4,"riseRate":0.375,"avgChangeRate":-0.020682},{"month":5,"riseRate":0.571429,"avgChangeRate":0.065461},{"month":6,"riseRate":0.714286,"avgChangeRate":0.081894},{"month":7,"riseRate":0.714286,"avgChangeRate":0.051469},{"month":8,"riseRate":0.571429,"avgChangeRate":0.08346},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.065825},{"month":10,"riseRate":0.285714,"avgChangeRate":0.030366},{"month":11,"riseRate":0.75,"avgChangeRate":0.130427},{"month":12,"riseRate":0.5,"avgChangeRate":-0.066498}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}